Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Retained Earnings (2018 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Retained Earnings for 8 consecutive years, with $857210.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 15382.76% year-over-year to $857210.0, compared with a TTM value of $857210.0 through Oct 2025, up 15382.76%, and an annual FY2025 reading of $867701.0, up 5017.67% over the prior year.
  • Retained Earnings was $857210.0 for Q4 2025 at VitaNova Life Sciences, up from $821400.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $867701.0 in Q2 2025 and bottomed at -$239365.0 in Q2 2021.
  • Average Retained Earnings over 5 years is $44524.2, with a median of -$95875.0 recorded in 2021.
  • The sharpest move saw Retained Earnings tumbled 65.26% in 2023, then soared 15382.76% in 2025.
  • Year by year, Retained Earnings stood at -$81793.0 in 2021, then decreased by 16.08% to -$94948.0 in 2022, then plummeted by 65.26% to -$156912.0 in 2023, then soared by 96.43% to -$5609.0 in 2024, then skyrocketed by 15382.76% to $857210.0 in 2025.
  • Business Quant data shows Retained Earnings for YJGJ at $857210.0 in Q4 2025, $821400.0 in Q3 2025, and $867701.0 in Q2 2025.